ATE495738T1 - Neue medizinische verwendung von alpha- ketoglutarat - Google Patents

Neue medizinische verwendung von alpha- ketoglutarat

Info

Publication number
ATE495738T1
ATE495738T1 AT07460015T AT07460015T ATE495738T1 AT E495738 T1 ATE495738 T1 AT E495738T1 AT 07460015 T AT07460015 T AT 07460015T AT 07460015 T AT07460015 T AT 07460015T AT E495738 T1 ATE495738 T1 AT E495738T1
Authority
AT
Austria
Prior art keywords
bacteria
ureolytic
ureolytic bacteria
ketoglutarate
infections
Prior art date
Application number
AT07460015T
Other languages
English (en)
Inventor
Danuta Kruszewska
Original Assignee
Danuta Kruszewska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danuta Kruszewska filed Critical Danuta Kruszewska
Application granted granted Critical
Publication of ATE495738T1 publication Critical patent/ATE495738T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT07460015T 2006-07-03 2007-07-03 Neue medizinische verwendung von alpha- ketoglutarat ATE495738T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL380103A PL226695B1 (pl) 2006-07-03 2006-07-03 Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori

Publications (1)

Publication Number Publication Date
ATE495738T1 true ATE495738T1 (de) 2011-02-15

Family

ID=38984524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07460015T ATE495738T1 (de) 2006-07-03 2007-07-03 Neue medizinische verwendung von alpha- ketoglutarat

Country Status (10)

Country Link
US (1) US20100124537A1 (de)
EP (1) EP1917959B1 (de)
AT (1) ATE495738T1 (de)
DE (1) DE602007012036D1 (de)
DK (1) DK1917959T3 (de)
ES (1) ES2360142T3 (de)
HR (1) HRP20110268T1 (de)
IL (1) IL233342A (de)
PL (2) PL226695B1 (de)
SI (1) SI1917959T1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
EP2046334B1 (de) 2006-07-25 2014-05-21 Vecta Ltd. Zusammensetzungen und verfahren zur hemmung von magensäuresekretion anhand von derivaten kleiner dicarbonsäuren in kombination mit ppi
SE0602446L (sv) * 2006-11-16 2008-05-17 Entress Ab Ny användning av kända farmakologiskt aktiva kemiska sammansättningar
PL2468319T3 (pl) 2010-11-29 2017-05-31 Eurochit Danuta Kruszewska Nowy nanoprodukt przydatny w zabiegach profilaktycznych, diagnostycznych oraz leczniczych w medycynie ludzkiej i w weterynarii
EP2674162A1 (de) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoprodukt, beinhaltend lactobacillus reuteri dan080, zur verwendung bei der prophylaxe, diagnose sowie bei der medizinischen and veterinärmedizinischen behandlung
CN104684565A (zh) 2012-05-29 2015-06-03 达努塔·克鲁谢夫斯卡 在人类和兽医的预防和医疗中有用的、包含罗伊氏乳杆菌dan080的纳米产品及其医疗用途
PL3398594T3 (pl) 2012-09-19 2024-11-04 Grespo Ab Kompozycje do ulepszenia funkcji mózgu
CN103923900B (zh) * 2014-04-14 2016-03-23 江南大学 一种黄酒用双功能酶交联酶聚集体的制备与应用
CN109803647A (zh) * 2016-09-30 2019-05-24 加州大学董事会 α-丁酮酸、α-酮戊二酸和2-羟基丁酸用于刺激毛发生长
CA3061381A1 (en) * 2017-04-25 2018-11-01 Buck Institute For Research On Aging COMPOSITIONS COMPRISING α-KETOGLUTARATE FOR EXTENDING LIFESPAN AND HEALTHSPAN
CN112955139B (zh) 2018-09-25 2025-04-18 庞塞迪利昂健康特定活动公司 用于制备α-酮戊二酸钙的方法
US20210369750A1 (en) * 2018-10-24 2021-12-02 Ponce De Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension
EP4175978A4 (de) * 2020-07-02 2024-06-26 Ponce de Leon Health Designated Activity Company Zusammensetzungen und verfahren zur behandlung von crp-vermittelten erkrankungen
CN115340313B (zh) * 2022-01-17 2023-04-18 浙江理工大学 一种物理复合微生物技术强化再生骨料方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919855B1 (de) 1970-10-06 1974-05-21
US4256731A (en) * 1978-03-23 1981-03-17 Beecham, Inc. Oral Compositions
US5028412A (en) * 1987-05-01 1991-07-02 Purdue Research Foundation Oral compositions comprising anti-calculus agents
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
AU764340B2 (en) * 1998-11-06 2003-08-14 Universite De Montreal Improved bactericidal and non-bactericidal solutions for removing biofilms
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
US7122578B2 (en) * 2001-09-11 2006-10-17 Alain Martin Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
SE0200256D0 (sv) * 2001-12-21 2002-01-29 Gramineer Internat Ab New composition, methods and use
PL368572A1 (en) * 2004-06-17 2005-12-27 Sgp & Sons Ab Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
CN101843609A (zh) 2005-11-15 2010-09-29 安特瑞斯公司 用于与软骨损伤有关的应用的药物
KR20080102372A (ko) * 2006-01-19 2008-11-25 엔트레스 에이비 진단 방법 및 치료 방법

Also Published As

Publication number Publication date
PL1917959T3 (pl) 2011-06-30
DK1917959T3 (da) 2011-05-09
PL226695B1 (pl) 2017-08-31
IL233342A (en) 2016-05-31
HRP20110268T1 (hr) 2011-05-31
SI1917959T1 (sl) 2011-05-31
ES2360142T3 (es) 2011-06-01
US20100124537A1 (en) 2010-05-20
EP1917959B1 (de) 2011-01-19
PL380103A1 (pl) 2008-01-07
IL233342A0 (en) 2014-08-31
EP1917959A1 (de) 2008-05-07
DE602007012036D1 (de) 2011-03-03

Similar Documents

Publication Publication Date Title
DE602007012036D1 (de) Neue medizinische Verwendung von Alpha-Ketoglutarat
JP3875262B2 (ja) 殺菌剤としての酸性化したニトリット
JP2010532347A5 (de)
BRPI0902901B8 (pt) bacteriófago e composição antibacteriana, alimento para animais, água potável, desinfetante, agente de limpeza e método para tratamento de doenças infecciosas compreendendo o mesmo
BR112013004206A2 (pt) novo bacteriófago isolado contendo atividade bactericida específica de e. coli e composição antibacteriana que compreende o mesmo
AU2020297184B2 (en) Biofilm disruption
JP2019524877A5 (de)
BR112021022632A2 (pt) Composições e métodos para tratar condições pulmonares relacionadas a biofilmes
CN103690937A (zh) 一种含海洋生物成分的儿童用龋齿口腔喷剂及其制备方法
CN104041516A (zh) 一种禽畜养殖屋消毒剂
Licker et al. Microbial biofilm in human health-an updated theoretical and practical insight
Ismail et al. Silver nanoparticles and sodium hypochlorite inhibitory effects on biofilm produced by Pseudomonas aeruginosa from poultry farms
Kishimoto et al. Mechanical tooth cleaning before chlorhexidine application
Ponnuraj et al. Influence of Limonia acidissima L. against the biofilm forming Aeromonas hydrophila isolated from fresh water fishes
Magdalenić et al. Antibacterial activity of Croatian honey of different botanical origin
JP2010513431A5 (de)
Guggenbichler Dramatic increase of multi-resistant microorganisms is self-inflicted. Effective and easy solutions are available
US10822315B2 (en) 5-benzylidene-4-oxazolidinones
RU2583890C2 (ru) Способ лечения гингивитов, пародонтитов и зубного камня у собак
W Williams et al. The oral cavity, biofilms and ventilator-associated pneumonia
Ajeel et al. The Effect of Cinnamomnum zeylanicum Extract on Pseudomonas aeruginosa Isolated from Burns and Purulent Wounds
Panigrahi et al. TOPIC: IMMUNOGLOBULIN Y IN IMPROVING ORAL HEALTH IN CHILDREN: A COMPREHENSIVE REVIEW
Panigrahi et al. Immunoglobulin Y In Improving Oral Health In Children: A Comprehensive Review
BRPI0605658B8 (pt) peptídeo antibiótico rico em glicina derivado de planta
Aliabadi et al. Effects of Mouthwash Matrica and Chlorhexidine in Preventing Nosocomial Pneumonia in the Intensive Care Unit: A Systematic Review

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1917959

Country of ref document: EP